NO165396C - Analogifremgangsmaate for fremstilling av terapeutisk aktive pyridin-5-karboksylsyre-estere. - Google Patents

Analogifremgangsmaate for fremstilling av terapeutisk aktive pyridin-5-karboksylsyre-estere.

Info

Publication number
NO165396C
NO165396C NO852049A NO852049A NO165396C NO 165396 C NO165396 C NO 165396C NO 852049 A NO852049 A NO 852049A NO 852049 A NO852049 A NO 852049A NO 165396 C NO165396 C NO 165396C
Authority
NO
Norway
Prior art keywords
preparation
carboxylic acid
acid esters
therapeutic active
active pyridine
Prior art date
Application number
NO852049A
Other languages
English (en)
Other versions
NO165396B (no
NO852049L (no
Inventor
Dante Nardi
Amedeo Leonardi
Giorgio Bianchi
Original Assignee
Recordati Chem Pharm
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Recordati Chem Pharm filed Critical Recordati Chem Pharm
Publication of NO852049L publication Critical patent/NO852049L/no
Publication of NO165396B publication Critical patent/NO165396B/no
Publication of NO165396C publication Critical patent/NO165396C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cardiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
NO852049A 1984-05-24 1985-05-22 Analogifremgangsmaate for fremstilling av terapeutisk aktive pyridin-5-karboksylsyre-estere. NO165396C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB848413385A GB8413385D0 (en) 1984-05-24 1984-05-24 Carboxylic acid derivatives

Publications (3)

Publication Number Publication Date
NO852049L NO852049L (no) 1985-11-25
NO165396B NO165396B (no) 1990-10-29
NO165396C true NO165396C (no) 1991-02-06

Family

ID=10561493

Family Applications (1)

Application Number Title Priority Date Filing Date
NO852049A NO165396C (no) 1984-05-24 1985-05-22 Analogifremgangsmaate for fremstilling av terapeutisk aktive pyridin-5-karboksylsyre-estere.

Country Status (25)

Country Link
US (1) US4634712A (no)
EP (1) EP0164213B1 (no)
JP (1) JPS6170A (no)
KR (1) KR890004128B1 (no)
CN (1) CN85104268A (no)
AR (1) AR240803A1 (no)
AT (1) ATE35258T1 (no)
AU (1) AU575946B2 (no)
CA (1) CA1261338A (no)
DE (1) DE3563439D1 (no)
DK (1) DK226685A (no)
EG (1) EG17343A (no)
ES (1) ES8703425A1 (no)
FI (1) FI80678C (no)
GB (1) GB8413385D0 (no)
GR (1) GR851264B (no)
HU (1) HU193763B (no)
IL (1) IL75196A (no)
MX (1) MX156875A (no)
NO (1) NO165396C (no)
NZ (1) NZ212111A (no)
PH (1) PH21946A (no)
PT (1) PT80521B (no)
SG (1) SG64488G (no)
ZA (1) ZA853394B (no)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58197775A (ja) * 1982-05-13 1983-11-17 Canon Inc 薄膜トランジスタ

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2847236A1 (de) * 1978-10-31 1980-05-14 Bayer Ag Neue dihydropyridine mit substituierten estergruppierungen, mehrer verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
JPS5762257A (en) * 1980-10-03 1982-04-15 Yoshitomi Pharmaceut Ind Ltd 1,4-dihydropyridine-3,5-dicarboxylic acid ester or its salt
JPS57175165A (en) * 1981-04-21 1982-10-28 Tokyo Tanabe Co Ltd Novel 1,4-dihydropyridine-3,5-dicarboxylic diester derivative and its salt
DE3377352D1 (en) * 1982-06-03 1988-08-18 Pierrel Spa Dihydropyridines with an antagonistic activity to calcium, process for their preparation, and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
AU4281185A (en) 1985-11-28
HU193763B (en) 1987-11-30
CA1261338A (en) 1989-09-26
AR240803A2 (es) 1991-02-28
GB8413385D0 (en) 1984-06-27
CN85104268A (zh) 1986-12-03
FI852002L (fi) 1985-11-25
DE3563439D1 (en) 1988-07-28
SG64488G (en) 1989-03-10
JPH0529030B2 (no) 1993-04-28
HUT38314A (en) 1986-05-28
NO165396B (no) 1990-10-29
DK226685A (da) 1985-11-25
KR850008155A (ko) 1985-12-13
NO852049L (no) 1985-11-25
ZA853394B (en) 1985-12-24
IL75196A (en) 1988-10-31
ES8703425A1 (es) 1987-02-16
FI80678B (fi) 1990-03-30
FI80678C (fi) 1990-07-10
GR851264B (no) 1985-11-25
ATE35258T1 (de) 1988-07-15
EP0164213A1 (en) 1985-12-11
PT80521B (en) 1986-12-16
DK226685D0 (da) 1985-05-22
EG17343A (en) 1990-12-30
MX156875A (es) 1988-10-07
ES543441A0 (es) 1987-02-16
NZ212111A (en) 1988-11-29
PH21946A (en) 1988-04-15
US4634712A (en) 1987-01-06
AR240803A1 (es) 1991-02-28
IL75196A0 (en) 1985-09-29
KR890004128B1 (ko) 1989-10-21
FI852002A0 (fi) 1985-05-20
AU575946B2 (en) 1988-08-11
EP0164213B1 (en) 1988-06-22
JPS6170A (ja) 1986-01-06
PT80521A (en) 1985-06-01

Similar Documents

Publication Publication Date Title
NO164418C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive naftyridin- og kinolin-karboksylsyre-forbindelser.
NO171209C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive morfinanestere
NO173238C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 7-beta-(karboksyalkenoylamino)-3-cefem-4-karboksylsyre-forbindelser
NO862734L (no) Fremgangsmaate for fremstilling av hyaluronsyreestere.
NO164025C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 3-imidazolylmetyl-tetrahydrokarbazolon-derivater.
NO162189C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazopyridiner.
NO864425D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive heterocyklyloksoftalazinyl-eddiksyre-derivater.
NO165397C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tiazolforbindelser.
NO862408D0 (no) Fremgangsmaate for fremstilling av thiazolidin-4(s)-karboksylsyrederivater.
NO171214C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive pyridonkarboksylsyrederivater
NO161497C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 9a-aza-9a-homoerytromycin-derivater.
NO164541C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzimidazolderivater.
NO163775C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive isoindolinyl-alkyl-piperaziner.
NO163692C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive oksazafosforin-4-tio-alkansulfonsyrer og salter derav.
NO172051C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive karboksylsyreesterderivater og deglukoteicoplanin
NO168041C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive retinsyreestere av erytromycin.
NO883046L (no) Fremgangsmaate til fremstilling av chinolonkarboksylsyrer.
NO157330C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive 3-metylflavon-8-karboksylsyreestere.
NO885221D0 (no) Estere av farmakologisk aktive karboksylsyrer.
NO884153D0 (no) Fremgangsmaate for fremstilling av fenoksyftalsyreanhydrider.
DK472388A (da) Fremgangsmaade til fremstilling af carboxylsyreestere
NO164899C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazolylindolforbindelser.
NO162188C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazokinoliner.
NO170930C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 4-okso-3-kinolinkarboksylsyrer
NO164243C (no) Analogifremgangsmaate for fremstilling av nye terapeutisk aktive 16,17-acetalsubstituerte pregnan-21-oinsyrederivater